Global Non-Laboratory-based Cannabis Testing Market - 2023-2030

Global Non-Laboratory-based Cannabis Testing Market - 2023-2030

The Global Non-Laboratory-based Cannabis Testing Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.

The term ""non-laboratory-based cannabis testing market"" describes cannabis testing procedures and products that can be carried out outside of a conventional laboratory. Customers, companies, and government agencies frequently utilize these techniques to guarantee the security, excellence, and adherence to regulations of cannabis products.

Convenient, on-the-spot testing is made possible by portable testing equipment and home testing kits. This accessibility lowers the time and expense involved in shipping samples to a laboratory, making it appealing to both consumers and corporations. The market for CBD generated from hemp is growing, and in order to stay in compliance with the law, non-laboratory testing is now required to verify the THC(tetrahydrocannabinol) content of goods.

Market Dynamics: Drivers

Rising Awareness of Health Benefits

Growing cannabis testing demand globally is opening up new growth opportunities for businesses in this and related industries. By investigating these prospects, organizations and potential investors can get a jump start on the competition. In recent years, there has been a notable trend toward increased understanding of the potential health advantages of various substances present in cannabis, especially cannabinoids like THC (tetrahydrocannabinol) and CBD (cannabidiol).

Narratives of people who have used cannabis-derived products and seen improvements in their health have been published by mainstream media outlets. These first-hand accounts and success stories have helped raise awareness. Cannabis and its possible health benefits have gained increased attention as more areas legalize or decriminalize it for either medical or recreational use. More candid conversations concerning its impact on health have resulted from this.

Public access to information regarding cannabis and its health advantages has increased. Businesses, advocacy groups, and organizations have all made investments to inform customers about the possible benefits of cannabis.

Limited Accuracy

When it comes to accuracy, non-laboratory-based testing procedures could not be as precise as laboratory testing. They might not offer the precision needed to meet some regulatory compliance requirements, despite being appropriate for a variety of uses. Non-laboratory-based testing solutions may find it difficult to satisfy the varied and changing needs of various markets due to the absence of uniform rules across areas.

Segment Analysis

The global non-laboratory-based cannabis testing market is segmented based on testing method, application and region.

The home testing kits segment accounted for approximately 54.7% of the market share

Cannabis home testing kits are made to enable users and small-scale cannabis farmers to evaluate the strength, safety, and quality of cannabis products in the comfort of their own homes. These kits give consumers useful information about the cannabis they are ingesting, like terpene profiles, possible contaminants like pesticides and heavy metals, and the amount of cannabinoids (like THC and CBD) in the plant.

Preventing addiction before it begins is the most effective strategy to reduce substance misuse; drug tests, when administered in the privacy of one's own home, are a safe and non-intrusive way to test children, adolescents, or loved ones for drug use. A straightforward, contact-free drug test is the Redi-Cup at-home drug test. The results can be accessed in five minutes and are simple to understand.

UK's Home Health provides the most widely used substance among individuals aged 11 to 25 is cannabis. Our One-Step Cannabis Test can identify cannabis for up to 30 days on average, with a sensitivity of 20ng.

The products come with a 10-test pack and a test sensitivity of 20 ng/mL. The European Workplace Drug Testing Society (EWDTS) criteria are met by our drug test sensitivities. About 7 to 30 days are the approximate measurable times it stays in the body after use. All tests have a 99% accuracy level and are CE-certified.

Geographical Analysis

North America accounted for approximately 45.6% of the market share

North America has been a dominant force in the global non-laboratory-based cannabis testing market. The United States has state-level regulations on cannabis, and each state has its own set of rules. Tests required by the state to guarantee that goods are suitable for sale also vary. Despite there being some limitations, the US market continues to be the largest globally, with the highest volume of sales.

This indicates a matching need for cannabis testing services. In terms of potential, that implies businesses should think about developing cannabis capabilities first in foreign markets where they may gain experience and scale under federal rules before expanding into US states where the biggest prospects are found.

The need for portable testing devices and home testing kits has been fueled by growing consumer awareness of the possible health benefits of cannabinoids like CBD as well as the significance of product safety and quality.

Numerous states in the United States have implemented medical cannabis initiatives, and patients depend on precise potency testing to establish the right dosage and evaluate the effectiveness of their treatment.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global non-laboratory-based cannabis testing market. Customers' worries about safety and the need for accurate product information increased as a result of the pandemic. As a result, there was a sharp increase in the market for home testing kits as people looked to confirm the legitimacy of the cannabis products they were buying, particularly for recreational and medicinal purposes.

Customers no longer needed to attend physical testing facilities because non-laboratory-based testing offered a contactless and practical means for them to evaluate their cannabis. This was especially helpful during lockdowns and social distancing.

By Testing Method
• Portable Testing Devices
Pesticide Testers
Potency Testers
Terpene Testers
Moisture and Water Activity Testers
• Home Testing Kits
At-Home THC Test Kits
Quick Pesticide Detection Kits
Home Microbial Test Kits

By Application
• Medical Cannabis
• Recreational Cannabis
• Hemp Products
• Cannabis Edibles
• Cannabis Beverages
• Topical Products
• Inhalable Products

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Purple Scientific, Orange Photonic Inc., Gemmacert, MyDx Inc., tCheck, ALPHA-CAT, Sage Analytics Inc., PharmLabs LLC, CannaSafe, and Steep Hill among others.

Why Purchase the Report?
• To visualize the global non-laboratory-based cannabis testing market segmentation based on testing method, application and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of non-laboratory-based cannabis testing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global non-laboratory-based cannabis testing market report would provide approximately 53 tables, 50 figures, and 186 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies